1,192 new Covid infections in Delhi; active cases rise for 3rd consecutive day
Welcome To CitySpidey

Location

1,192 new Covid infections in Delhi; active cases rise for 3rd consecutive day

1,108 patients recovered from the deadly virus in the last 24 hours.

1,192 new Covid infections in Delhi; active cases rise for 3rd consecutive day

New Delhi: Delhi reported 1,192 new coronavirus cases taking the tally to 1,42,723 on Friday. The death toll increased to 4,082 with 23 fatalities in the last 24 hours. In the last few days, the fatalities were 15 or less. 

For the third day in a row, new cases exceeded recoveries in the national capital, which is quite contrary to the daily figures reported since the start of July. On most days since the start of July, recoveries outnumbered the new cases. However, the margin was not too big.

1,108 patients recovered from the deadly virus in the last 24 hours taking the total recovery figure to 1,28,232. The recovery rate is above 89 per cent. 

The active cases increased by 61 on Friday. Delhi has now 10,409 active cases. It has been increasing in the last three days. The active cases had gone below 10,000 mark on August 5.

At present, 77.3 per cent (10,502) of beds are unoccupied at the Covid-19 hospitals. 

23,385 Covid tests were conducted in the last 24 hours. Out of that, 17,773 were rapid antigen tests and 5,612 were RTPCR, CBNAAT and True NAAT tests. Till date, a total of 11,43,703 tests have been conducted in the national capital.

Meanwhile, the collection of blood samples for the second round of serological survey was completed on Friday. Blood samples of over 15,000 people from eleven districts have been taken for the survey. 

As per the officials, the result of the survey will be out early next week. The survey will reflect the percentage of the city’s population who have developed antibodies against the coronavirus. 

During the first serological survey, which was conducted between June 27 and July 10, nearly 23 per cent of the population was found to have developed antibodies against the virus.